Prostate Cancer - Results from #22540

Novel approaches for the identification of biomarkers of aggressive prostate cancer - Abstract August 9, 2013

Barriers to prostate cancer prevention and community recommended health education strategies in an urban African American community in Jackson, Mississippi - Abstract August 8, 2013

Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database group - Abstract August 8, 2013

Molecular pathogenesis and progression of prostate cancer - Abstract August 8, 2013

Prostate cancer chemoprevention - Abstract August 8, 2013

Pushing the limits of radiation therapy for prostate cancer: Where do we go next? - Abstract August 8, 2013

Multimodality therapy for patients with high-risk prostate cancer: Current status and future directions - Abstract August 8, 2013

Non-castrate metastatic prostate cancer: Have the treatment options changed? - Abstract August 8, 2013

Perspectives on immunotherapy in prostate cancer and solid tumors: Where is the future? - Abstract August 8, 2013

Chemotherapy and targeted therapies: Are we making progress in castrate-resistant prostate cancer? - Abstract August 8, 2013

Retrospective study of predictors of bone metastasis in prostate cancer cases - Abstract August 8, 2013

Molecular biology of bone metastases - Abstract August 7, 2013

The type of patients who would benefit from anti-androgen withdrawal therapy: Could it be performed safely for aggressive prostate cancer? - Abstract August 7, 2013

Association of intensive morphine treatment and increased stroke incidence in prostate cancer patients: A population-based nested case-control study - Abstract August 7, 2013

Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trial - Abstract August 7, 2013

Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation - Abstract August 7, 2013

Increased rate of positive biopsies using a combination of MR-Tomography, spectroscopy and diffusion-weighted magnetic resonance imaging prior to prostate biopsies in patients with persistent elevated prostate-specific antigen values August 7, 2013

Shared decision making in prostate-specific antigen testing: The effect of a mailed patient flyer prior to an annual exam - Abstract August 7, 2013

Use of advanced treatment technologies among men at low risk of dying from prostate cancer - Abstract August 7, 2013

Differences in prostate cancer detection between Canadian and Saudi populations - Abstract August 7, 2013

Page 1128 of 1435